Juve Patent

JUVE is a media company located in Cologne, Germany, founded in 1997. It specializes in delivering in-depth journalistic insights across various sectors in the legal and tax industries. Our mission is to equip lawyers and tax advisors from law firms, tax consultancies, and corporate departments with trustworthy, unbiased information about their strengths and areas for improvement, along with updates on market trends and legal changes. This commitment is upheld by JUVE's dedicated team of expert journalists.

International

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#914794

United Kingdom

#151073

Law and Government/Legal

#787

Traffic sources

Monthly visitors

Articles

Zaun's appeal unsuccessful in Brexit-related case against Praesidiad

2 days ago | juve-patent.com | Mathieu Klos

The ruling came swiftly. On Friday, the UK Court of Appeal dismissed Zaun’s appeal against a UK High Court ruling (case ID: [2024] EWHC 1549 (Pat)) just nine days after the hearing. The case concerns high-security fence posts used to protect facilities such as oil fields. The dispute began in March 2018 when Betafence, later renamed Praesidiad, sued competitor Zaun for infringement of Community design right RCD 127204-0001. Both companies manufacture high-security fences.
Boehringer Ingelheim fails in bid for PI at local division Lisbon

5 days ago | juve-patent.com | Mathieu Klos

The UPC local division in Lisbon is not among the busiest in terms of case numbers. But as a relatively unknown entity compared to the established German local divisions, Lisbon has gained a reputation as an interesting venue for preliminary injunctions. According to the UPC’s latest statistics, Lisbon has heard one infringement claim and two preliminary injunction cases. It has already ruled on both PI applications, rejecting them in each instance.
Kinexon challenges Ballinno's offside patent with help from Bardehle

6 days ago | juve-patent.com | Mathieu Klos

Ballinno’s EP 1 944 067 covers a “method and system for detecting an offside situation”. The technology analyses an audio signal to determine when a player kicks the ball, which a referee can then use to ascertain if another player was offside at that moment. Thus, EP 067 is an extension of the video assistant referee (VAR), albeit with its technology specifically applied to the offside rule.
ToolGen and Vertex focus battle over CRISPR/Cas therapy Casgevy in Europe

6 days ago | juve-patent.com | Mathieu Klos

Biotech companies have fought over CRISPR/Cas patents for years, primarily at patent offices around the world. Now the technology has reached civil courts. Months ago, Korean biotech company ToolGen announced it would file patent infringement suits against Vertex. ToolGen is targeting the first therapy using CRISPR/Cas technology.
Gucci does not infringe Agfa leather printing patent

1 week ago | juve-patent.com | Christina Schulze

Printing company Agfa sued luxury goods brand Gucci for patent infringement. The case concerns Agfa’s patent EP 3 388 490, which covers a manufacturing method for embellishing natural leather with decorative images. This represents a key future field for Agfa. The company accused Gucci of using this method to decorate leather products, with the patent dispute centring on Gucci’s Pikarar Collection.
Taylor Wessing launches Paris patent practice with team from Pinsent Masons

1 week ago | juve-patent.com | Konstanze Richter

Full-service firm Taylor Wessing already has an IP team in the French capital focusing mainly on soft IP. The new dedicated patent team will launch with four litigators. Marina Jonon joins as counsel and Louise Millot as associate, both following Fabre from Pinsent Masons. Millot had moved to Pinsent Masons from August Debouzy just a year ago. A third associate, Clémence de Marassé-Enouf, will arrive from A&O Shearman in June.
Former Carpmaels partner to lead Mewburn Ellis' patent litigation push

1 week ago | juve-patent.com | Mathieu Klos

Balleny worked at Carpmaels & Ransford for ten years, most recently as equity partner, before leaving in December 2024. Her next move remained unknown for several months. Now, the life sciences patent litigator has joined Mewburn Ellis. Like Carpmaels, the firm is one of the UK’s leading practices for life sciences patents with a strong focus on patent attorney work. Unlike Balleny’s former firm, however, Mewburn Ellis has not historically maintained a large litigation practice.
UK Court of Appeal orders Apple to pay Optis more money in FRAND dispute

1 week ago | juve-patent.com | Mathieu Klos

Reuters reported that an Optis spokesperson welcomed the ruling, which they said “corrected a clearly flawed prior ruling and has made meaningful progress toward affirming the true value of our patents to Apple devices”. “We will continue to ensure fair compensation for the Optis intellectual property that enables high-speed connectivity for millions of devices around the world,” the spokesperson added.
South Korean medical device manufacturer Eoflow receives sales ban in UPC territory

1 week ago | juve-patent.com | Christina Schulze

Insulet has filed suits against Eoflow and Menarini over infringement of EP4 201 327, which protects insulin patch pumps. The European patent has unitary effect which can only be asserted before the UPC. Now, the Court of Appeal has ruled Eoflow must cease distribution and advertising of its insulin patch pumps in the UPC territory (case ID: UPC_CoA_768/2024, APL_64374/2024). The plaintiff can enforce the preliminary injunction without providing security.
First French decision on disparagement issue relating to pending UPC cases

1 week ago | juve-patent.com | Christina Schulze

From Europe. For the global patent community. JUVE Patent Cases First French decision on disparagement issue relating to pending UPC cases France 2 May 2025 by Christina Schulze On 3 March 2025, Qiagen published a press release announcing it had filed an infringement action against France-based company bioMérieux at the Düsseldorf local division of the UPC (case ID: ACT_9962/2025).